Percutaneous coronary intervention

Active Ingredient: Abciximab

Indication for Abciximab

Population group: only adults (18 years old or older)

Abciximab is indicated as an adjunct to heparin and acetylsalicylic acid for the prevention of ischaemic cardiac complications in patients undergoing percutaneous coronary intervention (PCI: balloon angioplasty, atherectomy, and stent).

For this indication, competent medicine agencies globally authorize below treatments:

0.25mg/kg intravenous bolus

Route of admnistration

Intravenous

Defined daily dose

0.25 mg per kg of body weight

Dosage regimen

0.25 mg per kg of body weight once every day

Detailed description

The recommended dose of Abciximab is a 0.25mg/kg intravenous bolus immediately followed by a 0.125 microgram/kg/min (to a maximum of 10 microgram/min) continuous intravenous infusion.

For the stabilisation of unstable angina patients, the bolus dose followed by the infusion should be started up to 24 hours prior to the possible intervention and concluded 12 hours after the intervention.

For the prevention of ischaemic cardiac complications in patients undergoing percutaneous coronary intervention, and who are not currently receiving an abciximab infusion, the bolus should be administered 10 to 60 minutes prior to the intervention followed by the infusion for 12 hours.

Active ingredient

Abciximab

Abciximab is the Fab fragment of the chimeric monoclonal antibody 7E3. It is directed against the glycoprotein (GP) IIb/IIIa (αIIbβ3) receptor located on the surface of human platelets. Abciximab inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules to GPIIb/IIIa receptor sites on activated platelets.

Read more about Abciximab

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.